Article
Preferential tendon stem cell response to growth factor supplementation
29 Jan 2014
Abstract excerpt
Tendon injuries are increasingly prevalent around the world, accounting for more than 100 000 new clinical cases/year in the USA alone. Cell-based therapies have been proposed as a therapeutic strategy, with recent data advocating the use of tendon stem cells (TSCs) as a potential cell source with clinical relevance for tendon regeneration. However, their in vitro expansion is problematic, as they lose their...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
